| Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma R Galot, C van Marcke, R Helaers, A Mendola, RM Goebbels, X Caignet, ... Oral oncology 104, 104631, 2020 | 51 | 2020 |
| Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data C van Marcke, A Collard, M Vikkula, FP Duhoux Critical reviews in oncology/hematology 132, 138-144, 2018 | 43 | 2018 |
| Liquid biopsy to detect minimal residual disease: methodology and impact N Honoré, R Galot, C van Marcke, N Limaye, JP Machiels Cancers 13 (21), 5364, 2021 | 37 | 2021 |
| Predictive biomarkers of response to neoadjuvant chemotherapy in breast cancer: current and future perspectives for precision medicine F Derouane, C van Marcke, M Berlière, A Gerday, L Fellah, I Leconte, ... Cancers 14 (16), 3876, 2022 | 30 | 2022 |
| Routine use of gene panel testing in hereditary breast cancer should be performed with caution C van Marcke, A De Leener, M Berlière, M Vikkula, FP Duhoux Critical Reviews in Oncology/Hematology 108, 33-39, 2016 | 24 | 2016 |
| Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer MR Van Bockstal, F Noel, Y Guiot, FP Duhoux, F Mazzeo, C Van Marcke, ... Annals of Diagnostic Pathology 49, 151634, 2020 | 19 | 2020 |
| Rapid and fatal acute heart failure induced by pazopanib C van Marcke, B Ledoux, B Petit, E Seront Case Reports 2015, bcr2015211522, 2015 | 19 | 2015 |
| CO2 measurement for the early differential diagnosis of pulmonary embolism-related shock at the emergency department: a case series C Van Marcke, A Daoudia, A Penaloza, F Verschuren Respiratory Medicine Case Reports 16, 106-108, 2015 | 15 | 2015 |
| Tucatinib and trastuzumab for previously treated human epidermal growth factor receptor 2–Positive metastatic biliary tract cancer (SGNTUC-019): a phase II basket study Y Nakamura, N Mizuno, Y Sunakawa, JL Canon, MD Galsky, E Hamilton, ... Journal of clinical oncology 41 (36), 5569-5578, 2023 | 14 | 2023 |
| Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients F Gourgue, F Derouane, C van Marcke, E Villar, H Dano, L Desmet, ... Scientific reports 11 (1), 9922, 2021 | 12 | 2021 |
| Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study C van Marcke, N Honoré, A van der Elst, S Beyaert, F Derouane, ... BMC cancer 21 (1), 578, 2021 | 10 | 2021 |
| Preclinical evaluation of the association of the cyclin-dependent kinase 4/6 inhibitor, ribociclib, and cetuximab in squamous cell carcinoma of the head and neck G van Caloen, S Schmitz, C Van Marcke, X Caignet, A Mendola, ... Cancers 13 (6), 1251, 2021 | 8 | 2021 |
| Palmar fasciitis and polyarthritis, a rare paraneoplastic syndrome related to ovarian cancer C van Marcke, E Seront, C Docquier, B Filleul Clinical and Experimental Dermatology 42 (3), 328-330, 2017 | 8 | 2017 |
| Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families C Van Marcke, R Helaers, A De Leener, A Merhi, CA Schoonjans, ... Breast cancer research 22, 1-13, 2020 | 7 | 2020 |
| Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck N Honoré, C van Marcke, R Galot, R Helaers, J Ambroise, A van Maanen, ... Annals of Oncology 34 (12), 1175-1186, 2023 | 6 | 2023 |
| Case report series: Aggressive HR deficient colorectal cancers related to BRCA1 pathogenic germline variants MV Freire, M Martin, R Thissen, C Van Marcke, K Segers, E Sépulchre, ... Frontiers in oncology 12, 835581, 2022 | 5 | 2022 |
| 1990MO Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial A Dowlati, A Cervantes, S Babu, EP Hamilton, SF Wong, A Tazbirkova, ... Annals of Oncology 34, S1061-S1062, 2023 | 4 | 2023 |
| PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment J Thouvenin, C Van Marcke, L Decoster, G Raicevic, K Punie, ... ESMO open 7 (4), 100524, 2022 | 4 | 2022 |
| Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future T Geukens, M Brandão, A Laenen, J Collignon, C Van Marcke, I Louviaux, ... ESMO open 7 (6), 100610, 2022 | 3 | 2022 |
| A federated learning system for precision oncology in Europe: DigiONE P Mahon, I Chatzitheofilou, A Dekker, X Fernández, G Hall, A Helland, ... Nature Medicine, 1-4, 2024 | 2 | 2024 |
